This was the stock's second consecutive day of gains.

The new versions of BD flow cytometer instrument software compatible with Biosero automation software for the BD FACSymphony A1™ Cell Analyzer, BD FACSymphony™ A5 SE Cell Anal ...

Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging Becton, Dickinson and Company’s (BD) blood collection device.

In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Gateway Investment Advisers LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by ...

About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, ...

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...